Martin Verronneau
CEO & President

Mr. Verronneau has more than twenty +years of sales and management experience in both the pharmaceutical and real estate sector. He started as a Family Medicine Sales Representative in 1998 to more recently Vice President Business Development. He worked in different environment ranging from American publicly traded to European privately owned to Canadian start-up and soon to be listed companies. He holds a Bachelor of Science degree from Université de Montréal and is accredited in Cardiology, Neurology and Respirology by the Council for Continuing Pharmaceutical Education. He also served as a member of the Board for the Quebec Hypertension Society.

Nadeem Siddiqui, B.Sc., M.Sc., Ph.D.
Chief Scientific Officer

Dr. Siddiqui is a research scientist at the Dept. of Biochemistry at McGill University and studies mRNA metabolism and protein synthesis in cancer. He has 25 years of experience working in the academic space and over thirty peer-reviewed publications. He also worked as a consultant and has been on the advisory board in various industries including medical device, insurance, hedge-fund management, and the medical cannabis space.  He holds a Ph.D. in Biochemistry (McGill) specializing in biophysics. 

Harnessing the Power of Gene Expression for
Early Cancer Detection